VERTEX PHARMAC. DL-,01

VX1 XETRA / Francfort Healthcare & Biotech United States
384.40
0.45 %

Vertex Pharmaceuticals focuses on the development and commercialization of drugs for the treatment of serious diseases such as cystic fibrosis.

Performance & Momentum

6 Months 1.72 %
1 Year 2.10 %
3 Years 24.46 %
5 Years 138.76 %

Similar stocks to VERTEX PHARMAC. DL-,01

Anantys Community

Be the first to share your analysis on VERTEX PHARMAC. DL-,01.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases